News

3/10/20

University at Buffalo researchers have discovered a link between fats in the blood and problems with the arteries in multiple sclerosis (MS) patients.

1/9/20

Fifteen students in the MD-PhD program at the Jacobs School of Medicine and Biomedical Sciences presented posters at the Tri-Institutional MD-PhD Research Day last fall at the Jacobs School building in downtown Buffalo.

12/3/19

Tracey A. Ignatowski, PhD, assistant professor of pathology and anatomical sciences, has developed a treatment for chronic pain that could have an impact in dealing with the opioid crisis.

11/15/19

Sixty-seven oral and poster presentations were showcased at the 13th annual Neuroscience Research Day of the neuroscience program and the Buffalo Chapter of the Society for Neuroscience (SfN).

11/12/19

Atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which patients will progress to the most severe form of multiple sclerosis (MS), according to a retrospective, five-year study of 1,314 MS patients.

10/31/19

The new program, leading to a Bachelor of Science degree, was developed as a collaboration between the Jacobs School of Medicine and Biomedical Sciences and the College of Arts and Sciences.

7/1/19

The PhD Program in Biomedical Sciences (PPBS) conducted its third annual white coat ceremony to recognize 19 students from the Class of 2018-2019 — 14 doctoral students and five MD-PhD students — who completed their first year in the program and are moving on to their research laboratory match.

6/5/19

Twenty-nine doctoral, 36 master’s and 154 baccalaureate candidates were eligible to receive degrees in biomedical science fields during the May commencement ceremony.

12/18/18

New stem cell research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified novel therapeutic targets for the treatment of multiple sclerosis (MS) and other inflammatory diseases.